Rare diseases
Investigational molecules
Locations
Back to Spain62 clinical trials in Manresa, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainStudy on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer
SpainA study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy
SpainWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
SpainA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
SpainSpainComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
SpainStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
SpainStudy on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer
SpainStudy on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
SpainStudy on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy
SpainA Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on triple-negative breast cancer and HER2-positive breast cancer treatments, evaluating innovative therapies including atezolizumab, abemaciclib, and elacestrant.
Studies aim to improve survival rates and treatment outcomes through personalized therapeutic approaches.
Groundbreaking research in urothelial cancer and prostate cancer treatments, investigating novel combinations of immunotherapy and targeted therapies.
Focus on improving progression-free survival through innovative treatment combinations.
Advanced research in severe asthma and lung cancer treatments, exploring new therapeutic approaches including immunotherapy combinations.
Innovative approaches combining surgery, chemotherapy, and immunotherapy for optimal patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
